NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Emcure Pharmaceuticals achieved a significant milestone in FY26 by surpassing $1 billion in annual revenue, driven by a 16.6% growth in total income. The company reported a robust 41% increase in adjusted PAT, underpinned by strong expansion in international markets and a resilient domestic portfolio.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
